NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 140 filers reported holding NOVAVAX INC in Q2 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,467,000 | -77.5% | 1,666,893 | -21.5% | 0.36% | -80.3% |
| Q2 2016 | $15,442,000 | +107.4% | 2,124,035 | +47.2% | 1.82% | +97.5% |
| Q1 2016 | $7,445,000 | +107.6% | 1,442,902 | +184.4% | 0.92% | +96.2% |
| Q4 2015 | $3,587,000 | 0.0% | 507,344 | 0.0% | 0.47% | +0.6% |
| Q3 2015 | $3,587,000 | -59.3% | 507,344 | -35.9% | 0.47% | -54.9% |
| Q2 2015 | $8,814,000 | -18.8% | 791,161 | -39.7% | 1.04% | -11.7% |
| Q1 2015 | $10,850,000 | -19.0% | 1,311,944 | -41.9% | 1.17% | -27.0% |
| Q4 2014 | $13,396,000 | +55.4% | 2,259,077 | +9.3% | 1.61% | +75.8% |
| Q3 2014 | $8,618,000 | -10.0% | 2,066,679 | -0.3% | 0.92% | -1.1% |
| Q2 2014 | $9,579,000 | +21.9% | 2,073,272 | +19.5% | 0.92% | +16.1% |
| Q1 2014 | $7,860,000 | – | 1,735,278 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |